The Exchange has sought clarification from IOL Chemicals and Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act. -2. 2013 or as per Indian Accounting Standard. The response of the Company is awaited.
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE has asked IOL Chemicals and Pharmaceuticals to explain why its financial results for the quarter ended 31 December 2025 do not follow the format prescribed under Schedule III of the Companies Act. A second query appears to relate to whether the results were prepared as per the applicable Indian Accounting Standards. The company has not yet replied to the Exchange, and its response is awaited. Until the company clarifies and the Exchange is satisfied, the filed results remain under question. The issue is procedural in nature and does not necessarily reflect any wrongdoing or financial irregularity.
Short-term uncertainty for the stock as investors wait for the company's response. If resolved quickly with a satisfactory explanation, the impact may be minimal; a delayed or unsatisfactory reply could lead to further regulatory action or affect trading sentiment.